ストックスクリーナーアプリを入手
40.54
0.12%
-0.05
Indivior Pharmaceuticals Inc (INDV) 最新ニュース
INDIVIOR PHARMACEUTICALS INC (NASDAQ:INDV) Shows Breakout Setup With Perfect Technical Strength Score - ChartMill
Price to earnings forward of Indivior Pharmaceuticals, Inc. – MUN:E7P - TradingView
Indivior Pharmaceuticals Inc (INDV) Insider Sell: Christian Heid - GuruFocus
Form 144 Indivior Pharmaceuticals For: 10 July By Investing.com - Investing.com Nigeria
INDV (NASDAQ: INDV) files Form 144 reporting 18,586 shares and $764,628 value - Stock Titan
Enterprise value to EBIT forward of Indivior Pharmaceuticals, Inc. – DUS:E7P - TradingView
How Indivior’s Multi-Index Russell 2000 Defensive Inclusion (INDV) Has Changed Its Investment Story - simplywall.st
Enterprise value to EBITDA forward of Indivior Pharmaceuticals, Inc. – DUS:E7P - TradingView
Is Indivior Pharmaceuticals (INDV) Fully Valued As Russell 2000 Index Additions Draw Buyers? - simplywall.st
Indivior Pharmaceuticals Inc. (INDV) is on the move, here's why the trend could be sustainable - MSN
Indivior Pharmaceuticals, Inc. Financial Disclosures & Filings - TradingView
Indivior’s Triple Russell 2000 Defensive Inclusion Could Be A Game Changer For Indivior Pharmaceuticals (INDV) - Yahoo Finance
Indivior added to Russell 2000 defensive indices, shares gain visibility with US investors - ad-hoc-news.de
Indivior Pharmaceuticals Inc. (INDV) is on the Move, Here's Why the Trend Could be Sustainable - Yahoo Finance
Does Indivior (INDV) Joining Multiple Russell 2000 Defensive Indices Recast Its Opioid-Treatment Narrative? - simplywall.st
Indivior Pharmaceuticals, Inc.(NasdaqGS:INDV) added to Russell 2000 Value-Defensive Index - marketscreener.com
Indivior Pharmaceuticals, Inc.(NasdaqGS:INDV) added to Russell 2000 Growth-Defensive Index - marketscreener.com
Indivior Pharmaceuticals, Inc.(NasdaqGS: INDV) added to Russell 2000 Defensive Index - marketscreener.com
Indivior consensus shapes expectations, shares on Nasdaq under analyst scrutiny - ad-hoc-news.de
INDV Forecast — Price Target — Prediction for 2027 - TradingView
Enterprise value to revenue forward of Indivior Pharmaceuticals, Inc. – NASDAQ:INDV - TradingView
Price to book forward of Indivior Pharmaceuticals, Inc. – NASDAQ:INDV - TradingView
Enterprise value to revenue forward of Indivior Pharmaceuticals, Inc. – BMV:INDV1 - TradingView
Price to sales forward of Indivior Pharmaceuticals, Inc. – NASDAQ:INDV - TradingView
Price to book forward of Indivior Pharmaceuticals, Inc. – BMV:INDV1 - TradingView
Price to sales forward of Indivior Pharmaceuticals, Inc. – BMV:INDV1 - TradingView
Enterprise value to EBITDA forward of Indivior Pharmaceuticals, Inc. – BMV:INDV1 - TradingView
Zacks Industry Outlook Indivior, Aurinia, Ironwood, Altimmune and Marker - The Globe and Mail
Indivior Pharmaceuticals, Inc. Actuals & Estimates (LS:A42086) - TradingView
Indivior Pharmaceuticals, Inc. Actuals & Estimates (NASDAQ:INDV) - TradingView
Enterprise value to EBIT forward of Indivior Pharmaceuticals, Inc. – BMV:INDV1 - TradingView
Is Big Pharma's Patent Cliff Driving a New M&A Wave - Kavout | AI
Price to earnings forward of Indivior Pharmaceuticals, Inc. – BMV:INDV1 - TradingView
E7P Forecast — Price Target — Prediction for 2027 - TradingView
IBD 50 stock Indivior breaks out amid big fund ownership expansion, strong profit prospects - MSN
Reasons Why Investors Should Consider Betting on Indivior Stock - The Globe and Mail
A42086 Forecast — Price Target — Prediction for 2027 - TradingView
Form 4 Indivior PLC For: 23 June By Investing.com - Investing.com Australia
Indivior Pharmaceuticals (INDV) CEO vests 1.27M shares, 612K for taxes - Stock Titan
Indivior gains new overweight at Barclays on business turnaround - MSN
Does Indivior Pharmaceuticals Inc. (INDV) have the potential to rally 32.48% as Wall Street analysts expect? - MSN
Indivior Pharmaceuticals (INDV) Stock Could Be 23% Undervalued As Cost Cut Narrative Builds - Sahm
INDV News | INDIVIOR PHARMACEUTICALS INC (NASDAQ:INDV) - ChartMill
INDIVIOR PHARMACEUTICALS INC (INDV) Stock Chart - ChartMill
Indivior stock gains new Overweight at Barclays (INDV:NASDAQ) - Seeking Alpha
Barclays Initiates Indivior at Overweight With $46 Price Target - marketscreener.com
Indivior PLC (INDV) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Indivior PLC (INDV) Institutional Confidence - TradingKey
How Investors Are Reacting To Indivior (INDV) Upgraded 2026 Outlook And $175 Million Buyback Plan - Yahoo Finance
Suboxone Tooth Decay Lawsuit Updates for 2026 - Lawsuit Information Center
Indivior's Chief Scientific Officer Sold Over 18,000 Company Shares. Should Investors Worry? - Yahoo Finance
Is Indivior Pharmaceuticals, Inc. (INDV) A Good Stock To Buy Now? - Insider Monkey
Recent price trend in Indivior Pharmaceuticals Inc. (INDV) is your friend, here's why - MSN
1.50%
0.79%
大文字化:
|
ボリューム (24 時間):